Do special access programs facilitate off-label prescribing? The experience of enzalutamide in prostate cancer.
Nimira S. Alimohamed
No relevant relationships to disclose
Raya Leibowitz-Amit
No relevant relationships to disclose
Arnoud J. Templeton
No relevant relationships to disclose
Jo-An Seah
No relevant relationships to disclose
Francisco Emilio Vera-Badillo
No relevant relationships to disclose
Anthony M. Joshua
Consultant or Advisory Role - Astex Therapeutics (U)
Jennifer J. Knox
No relevant relationships to disclose
Ian Tannock
No relevant relationships to disclose
Srikala S. Sridhar
Consultant or Advisory Role - Astellas Pharma
Honoraria - Astellas Pharma